MedTrace Logo

A Clinical Trial of Ginseng in Diabetes

NCT00781534 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2019-09-09

No results posted yet for this study

Summary

a clinical study of Ginseng its potential affect on diabetes

Conditions

Interventions

DRUG

Ginseng

Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups

DRUG

Ginseng

DRUG

ginsenoside RE

active metabolite of ginseng

DIETARY_SUPPLEMENT

Placebo (sugar pill)

placebo group

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Kenneth S Polonsky, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2004-12-31
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00781534 on ClinicalTrials.gov